Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Disease

Symptomatic intracranial atherosclerotic disease (ICAD) is responsible for approximately 10% of all ischemic strokes in the United States. The risk of recurrent stroke may be as high as 35% in patient with critical stenosis >70% in diameter narrowing. Recent advances in medical and endovascular t...

Descripción completa

Detalles Bibliográficos
Autores principales: Short, Jody L., Majid, Arshad, Hussain, Syed I.
Formato: Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040367/
https://www.ncbi.nlm.nih.gov/pubmed/21359195
http://dx.doi.org/10.3389/fneur.2010.00160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040367/
https://www.ncbi.nlm.nih.gov/pubmed/21359195
http://dx.doi.org/10.3389/fneur.2010.00160

Ejemplares similares